nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCB1—peripheral nervous system neoplasm	0.277	1	CbGaD
Pitavastatin—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0714	0.123	CbGbCtD
Pitavastatin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0676	0.117	CbGbCtD
Pitavastatin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0469	0.0809	CbGbCtD
Pitavastatin—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0335	0.0578	CbGbCtD
Pitavastatin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0319	0.0551	CbGbCtD
Pitavastatin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0298	0.0514	CbGbCtD
Pitavastatin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0292	0.0505	CbGbCtD
Pitavastatin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0289	0.0498	CbGbCtD
Pitavastatin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0269	0.0464	CbGbCtD
Pitavastatin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0264	0.0456	CbGbCtD
Pitavastatin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0244	0.0421	CbGbCtD
Pitavastatin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0244	0.0421	CbGbCtD
Pitavastatin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0233	0.0403	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0199	0.0344	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.018	0.0311	CbGbCtD
Pitavastatin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0169	0.0292	CbGbCtD
Pitavastatin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0141	0.0243	CbGbCtD
Pitavastatin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0104	0.018	CbGbCtD
Pitavastatin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.01	0.0173	CbGbCtD
Pitavastatin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0097	0.0167	CbGbCtD
Pitavastatin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00953	0.0165	CbGbCtD
Pitavastatin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0065	0.0112	CbGbCtD
Pitavastatin—UGT2B7—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000707	0.0513	CbGpPWpGaD
Pitavastatin—SLC10A1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000685	0.0497	CbGpPWpGaD
Pitavastatin—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000561	0.0407	CbGpPWpGaD
Pitavastatin—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000527	0.0382	CbGpPWpGaD
Pitavastatin—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.000524	0.00404	CcSEcCtD
Pitavastatin—Back pain—Tretinoin—peripheral nervous system neoplasm	0.000524	0.00404	CcSEcCtD
Pitavastatin—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.000523	0.00403	CcSEcCtD
Pitavastatin—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00052	0.004	CcSEcCtD
Pitavastatin—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.000509	0.00392	CcSEcCtD
Pitavastatin—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.000507	0.00391	CcSEcCtD
Pitavastatin—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00387	CcSEcCtD
Pitavastatin—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00387	CcSEcCtD
Pitavastatin—Malaise—Topotecan—peripheral nervous system neoplasm	0.000493	0.0038	CcSEcCtD
Pitavastatin—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.000489	0.00377	CcSEcCtD
Pitavastatin—Malaise—Tretinoin—peripheral nervous system neoplasm	0.000489	0.00377	CcSEcCtD
Pitavastatin—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000482	0.00371	CcSEcCtD
Pitavastatin—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000476	0.0345	CbGpPWpGaD
Pitavastatin—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.00364	CcSEcCtD
Pitavastatin—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00047	0.00362	CcSEcCtD
Pitavastatin—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.000465	0.00358	CcSEcCtD
Pitavastatin—Myalgia—Topotecan—peripheral nervous system neoplasm	0.000465	0.00358	CcSEcCtD
Pitavastatin—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.000461	0.00356	CcSEcCtD
Pitavastatin—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.000461	0.00356	CcSEcCtD
Pitavastatin—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.000461	0.00356	CcSEcCtD
Pitavastatin—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000461	0.00356	CcSEcCtD
Pitavastatin—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00046	0.00354	CcSEcCtD
Pitavastatin—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.000456	0.00351	CcSEcCtD
Pitavastatin—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000456	0.00351	CcSEcCtD
Pitavastatin—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000456	0.00351	CcSEcCtD
Pitavastatin—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000452	0.00349	CcSEcCtD
Pitavastatin—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000447	0.0324	CbGpPWpGaD
Pitavastatin—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000446	0.00344	CcSEcCtD
Pitavastatin—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000446	0.00344	CcSEcCtD
Pitavastatin—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000414	0.03	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.00317	CcSEcCtD
Pitavastatin—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000408	0.0296	CbGpPWpGaD
Pitavastatin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000406	0.00313	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00311	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00311	CcSEcCtD
Pitavastatin—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0004	0.00308	CcSEcCtD
Pitavastatin—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0004	0.00308	CcSEcCtD
Pitavastatin—Jaundice—Etoposide—peripheral nervous system neoplasm	0.0004	0.00308	CcSEcCtD
Pitavastatin—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.0004	0.00308	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000398	0.00306	CcSEcCtD
Pitavastatin—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00306	CcSEcCtD
Pitavastatin—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000393	0.00302	CcSEcCtD
Pitavastatin—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000389	0.003	CcSEcCtD
Pitavastatin—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.003	CcSEcCtD
Pitavastatin—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000384	0.00296	CcSEcCtD
Pitavastatin—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000384	0.00296	CcSEcCtD
Pitavastatin—Back pain—Vincristine—peripheral nervous system neoplasm	0.000383	0.00295	CcSEcCtD
Pitavastatin—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000381	0.00294	CcSEcCtD
Pitavastatin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000381	0.00294	CcSEcCtD
Pitavastatin—Constipation—Topotecan—peripheral nervous system neoplasm	0.000381	0.00294	CcSEcCtD
Pitavastatin—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00294	CcSEcCtD
Pitavastatin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000378	0.00291	CcSEcCtD
Pitavastatin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000378	0.00291	CcSEcCtD
Pitavastatin—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000377	0.00291	CcSEcCtD
Pitavastatin—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000376	0.0029	CcSEcCtD
Pitavastatin—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000373	0.00287	CcSEcCtD
Pitavastatin—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00285	CcSEcCtD
Pitavastatin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000368	0.00283	CcSEcCtD
Pitavastatin—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000367	0.00282	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000365	0.00281	CcSEcCtD
Pitavastatin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00281	CcSEcCtD
Pitavastatin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00281	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000362	0.00279	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000362	0.00279	CcSEcCtD
Pitavastatin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000354	0.00273	CcSEcCtD
Pitavastatin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000353	0.00272	CcSEcCtD
Pitavastatin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000351	0.00271	CcSEcCtD
Pitavastatin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000351	0.00271	CcSEcCtD
Pitavastatin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00269	CcSEcCtD
Pitavastatin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00269	CcSEcCtD
Pitavastatin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00035	0.00269	CcSEcCtD
Pitavastatin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00035	0.00269	CcSEcCtD
Pitavastatin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000347	0.00267	CcSEcCtD
Pitavastatin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000346	0.00266	CcSEcCtD
Pitavastatin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.0026	CcSEcCtD
Pitavastatin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000337	0.0026	CcSEcCtD
Pitavastatin—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00259	CcSEcCtD
Pitavastatin—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000332	0.00256	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000329	0.00254	CcSEcCtD
Pitavastatin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000329	0.00253	CcSEcCtD
Pitavastatin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.00251	CcSEcCtD
Pitavastatin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000326	0.00251	CcSEcCtD
Pitavastatin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000325	0.0025	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00249	CcSEcCtD
Pitavastatin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000322	0.00248	CcSEcCtD
Pitavastatin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00032	0.00246	CcSEcCtD
Pitavastatin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00245	CcSEcCtD
Pitavastatin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00245	CcSEcCtD
Pitavastatin—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000316	0.00243	CcSEcCtD
Pitavastatin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000316	0.00243	CcSEcCtD
Pitavastatin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000313	0.00241	CcSEcCtD
Pitavastatin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000313	0.00241	CcSEcCtD
Pitavastatin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000313	0.00241	CcSEcCtD
Pitavastatin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.0024	CcSEcCtD
Pitavastatin—Back pain—Etoposide—peripheral nervous system neoplasm	0.00031	0.00239	CcSEcCtD
Pitavastatin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000309	0.00238	CcSEcCtD
Pitavastatin—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000308	0.00238	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.00237	CcSEcCtD
Pitavastatin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000307	0.0222	CbGpPWpGaD
Pitavastatin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00235	CcSEcCtD
Pitavastatin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000305	0.00235	CcSEcCtD
Pitavastatin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.00234	CcSEcCtD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000303	0.022	CbGpPWpGaD
Pitavastatin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000303	0.00233	CcSEcCtD
Pitavastatin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000303	0.00233	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.0023	CcSEcCtD
Pitavastatin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000299	0.0023	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000298	0.0023	CcSEcCtD
Pitavastatin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000298	0.0023	CcSEcCtD
Pitavastatin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.0023	CcSEcCtD
Pitavastatin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000298	0.00229	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000297	0.0215	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000296	0.00228	CcSEcCtD
Pitavastatin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.00227	CcSEcCtD
Pitavastatin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000295	0.00227	CcSEcCtD
Pitavastatin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000294	0.00227	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000294	0.00227	CcSEcCtD
Pitavastatin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000293	0.00225	CcSEcCtD
Pitavastatin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000293	0.00225	CcSEcCtD
Pitavastatin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000292	0.00225	CcSEcCtD
Pitavastatin—Malaise—Etoposide—peripheral nervous system neoplasm	0.000289	0.00223	CcSEcCtD
Pitavastatin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00223	CcSEcCtD
Pitavastatin—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000288	0.0209	CbGpPWpGaD
Pitavastatin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00221	CcSEcCtD
Pitavastatin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000286	0.0022	CcSEcCtD
Pitavastatin—Rash—Topotecan—peripheral nervous system neoplasm	0.000281	0.00217	CcSEcCtD
Pitavastatin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000281	0.00216	CcSEcCtD
Pitavastatin—Headache—Topotecan—peripheral nervous system neoplasm	0.000279	0.00215	CcSEcCtD
Pitavastatin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000279	0.00215	CcSEcCtD
Pitavastatin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000279	0.00215	CcSEcCtD
Pitavastatin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000279	0.00215	CcSEcCtD
Pitavastatin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000279	0.00215	CcSEcCtD
Pitavastatin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000279	0.00215	CcSEcCtD
Pitavastatin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00214	CcSEcCtD
Pitavastatin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00214	CcSEcCtD
Pitavastatin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00213	CcSEcCtD
Pitavastatin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000276	0.00213	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.00213	CcSEcCtD
Pitavastatin—Rash—Melphalan—peripheral nervous system neoplasm	0.000275	0.00212	CcSEcCtD
Pitavastatin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000275	0.00212	CcSEcCtD
Pitavastatin—UGT1A3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000274	0.0199	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.00211	CcSEcCtD
Pitavastatin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00027	0.00208	CcSEcCtD
Pitavastatin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000267	0.00206	CcSEcCtD
Pitavastatin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000266	0.00205	CcSEcCtD
Pitavastatin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.00205	CcSEcCtD
Pitavastatin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.00204	CcSEcCtD
Pitavastatin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000265	0.00204	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000264	0.00204	CcSEcCtD
Pitavastatin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000264	0.00203	CcSEcCtD
Pitavastatin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000263	0.00202	CcSEcCtD
Pitavastatin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000263	0.00202	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00201	CcSEcCtD
Pitavastatin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.002	CcSEcCtD
Pitavastatin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000259	0.002	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00199	CcSEcCtD
Pitavastatin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000255	0.00197	CcSEcCtD
Pitavastatin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000247	0.00191	CcSEcCtD
Pitavastatin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.0019	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.0019	CcSEcCtD
Pitavastatin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00185	CcSEcCtD
Pitavastatin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.00184	CcSEcCtD
Pitavastatin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000238	0.00183	CcSEcCtD
Pitavastatin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00183	CcSEcCtD
Pitavastatin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000235	0.00181	CcSEcCtD
Pitavastatin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000232	0.00179	CcSEcCtD
Pitavastatin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00177	CcSEcCtD
Pitavastatin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000228	0.00176	CcSEcCtD
Pitavastatin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000226	0.00174	CcSEcCtD
Pitavastatin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000224	0.00173	CcSEcCtD
Pitavastatin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000224	0.00172	CcSEcCtD
Pitavastatin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.00171	CcSEcCtD
Pitavastatin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000221	0.0017	CcSEcCtD
Pitavastatin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000216	0.00166	CcSEcCtD
Pitavastatin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000215	0.00165	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000214	0.00165	CcSEcCtD
Pitavastatin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000214	0.00165	CcSEcCtD
Pitavastatin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00163	CcSEcCtD
Pitavastatin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.00163	CcSEcCtD
Pitavastatin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00162	CcSEcCtD
Pitavastatin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00162	CcSEcCtD
Pitavastatin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000208	0.0016	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.0016	CcSEcCtD
Pitavastatin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000207	0.00159	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00159	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00158	CcSEcCtD
Pitavastatin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00158	CcSEcCtD
Pitavastatin—Rash—Vincristine—peripheral nervous system neoplasm	0.000204	0.00157	CcSEcCtD
Pitavastatin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000204	0.00157	CcSEcCtD
Pitavastatin—Headache—Vincristine—peripheral nervous system neoplasm	0.000202	0.00156	CcSEcCtD
Pitavastatin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.00153	CcSEcCtD
Pitavastatin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000195	0.00151	CcSEcCtD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000194	0.0141	CbGpPWpGaD
Pitavastatin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000193	0.00149	CcSEcCtD
Pitavastatin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000192	0.00148	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00147	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00146	CcSEcCtD
Pitavastatin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000188	0.00145	CcSEcCtD
Pitavastatin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000185	0.00143	CcSEcCtD
Pitavastatin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000185	0.0134	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000183	0.0133	CbGpPWpGaD
Pitavastatin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00139	CcSEcCtD
Pitavastatin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00139	CcSEcCtD
Pitavastatin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000179	0.00138	CcSEcCtD
Pitavastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000176	0.0128	CbGpPWpGaD
Pitavastatin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00134	CcSEcCtD
Pitavastatin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000173	0.00133	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00133	CcSEcCtD
Pitavastatin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00017	0.00131	CcSEcCtD
Pitavastatin—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000168	0.0122	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00128	CcSEcCtD
Pitavastatin—Rash—Etoposide—peripheral nervous system neoplasm	0.000165	0.00127	CcSEcCtD
Pitavastatin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000165	0.00127	CcSEcCtD
Pitavastatin—Headache—Etoposide—peripheral nervous system neoplasm	0.000164	0.00126	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00125	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00124	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00123	CcSEcCtD
Pitavastatin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000155	0.0012	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00119	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00118	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00118	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00116	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00116	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000148	0.0107	CbGpPWpGaD
Pitavastatin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00114	CcSEcCtD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000145	0.0105	CbGpPWpGaD
Pitavastatin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00109	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00109	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00108	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00105	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000133	0.00961	CbGpPWpGaD
Pitavastatin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000995	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000974	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000966	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000953	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000946	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000931	CcSEcCtD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000121	0.00876	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000924	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00092	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000119	0.00859	CbGpPWpGaD
Pitavastatin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000902	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000898	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000894	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000893	CcSEcCtD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000114	0.0083	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000114	0.00828	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000862	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000855	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000833	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000831	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000827	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000811	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000104	0.0008	CcSEcCtD
Pitavastatin—UGT1A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000103	0.00748	CbGpPWpGaD
Pitavastatin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000773	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00077	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.77e-05	0.00708	CbGpPWpGaD
Pitavastatin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.00075	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000747	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.00074	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000715	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	9.28e-05	0.00673	CbGpPWpGaD
Pitavastatin—Rash—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000713	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000712	CcSEcCtD
Pitavastatin—Headache—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000708	CcSEcCtD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	9.01e-05	0.00654	CbGpPWpGaD
Pitavastatin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000691	CcSEcCtD
Pitavastatin—UGT2B7—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	8.77e-05	0.00636	CbGpPWpGaD
Pitavastatin—Nausea—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000671	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000659	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000659	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000655	CcSEcCtD
Pitavastatin—HMGCR—TOR Signaling—AKT1—peripheral nervous system neoplasm	8.42e-05	0.00611	CbGpPWpGaD
Pitavastatin—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.12e-05	0.00589	CbGpPWpGaD
Pitavastatin—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000621	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.96e-05	0.00577	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	7.91e-05	0.00574	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.85e-05	0.00569	CbGpPWpGaD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.74e-05	0.00561	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.54e-05	0.00547	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	6.96e-05	0.00504	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—HGF—peripheral nervous system neoplasm	6.72e-05	0.00488	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.6e-05	0.00478	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.49e-05	0.00471	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.23e-05	0.00452	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	6.17e-05	0.00448	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.13e-05	0.00444	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.12e-05	0.00443	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—TP53—peripheral nervous system neoplasm	5.93e-05	0.0043	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.88e-05	0.00427	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	5.56e-05	0.00403	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.52e-05	0.004	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.48e-05	0.00398	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.38e-05	0.0039	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	5.33e-05	0.00387	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	5.29e-05	0.00384	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.18e-05	0.00376	CbGpPWpGaD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	5.11e-05	0.00371	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—AKT1—peripheral nervous system neoplasm	5.01e-05	0.00363	CbGpPWpGaD
Pitavastatin—HMGCR—SREBP signalling—AKT1—peripheral nervous system neoplasm	5.01e-05	0.00363	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.94e-05	0.00358	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GNS—peripheral nervous system neoplasm	4.77e-05	0.00346	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	4.63e-05	0.00336	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—NME1—peripheral nervous system neoplasm	4.57e-05	0.00332	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.54e-05	0.00329	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.47e-05	0.00324	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	4.41e-05	0.0032	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—COX2—peripheral nervous system neoplasm	4.4e-05	0.00319	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.38e-05	0.00318	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.21e-05	0.00305	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.13e-05	0.003	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.12e-05	0.00299	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.11e-05	0.00298	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.99e-05	0.00289	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.95e-05	0.00287	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GNS—peripheral nervous system neoplasm	3.89e-05	0.00282	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	3.86e-05	0.0028	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.8e-05	0.00276	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NME1—peripheral nervous system neoplasm	3.73e-05	0.0027	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.73e-05	0.0027	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.66e-05	0.00265	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—COX2—peripheral nervous system neoplasm	3.59e-05	0.0026	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.58e-05	0.0026	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.56e-05	0.00258	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.43e-05	0.00249	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.21e-05	0.00233	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	3.17e-05	0.0023	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.17e-05	0.0023	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.15e-05	0.00228	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.11e-05	0.00226	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	3.04e-05	0.0022	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	2.99e-05	0.00217	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	2.92e-05	0.00212	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.91e-05	0.00211	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.89e-05	0.0021	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	2.86e-05	0.00208	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.78e-05	0.00201	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	2.76e-05	0.002	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	2.69e-05	0.00195	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.68e-05	0.00194	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	2.58e-05	0.00187	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.57e-05	0.00186	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.54e-05	0.00184	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.51e-05	0.00182	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	2.49e-05	0.0018	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.48e-05	0.0018	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.46e-05	0.00179	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.46e-05	0.00178	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.45e-05	0.00178	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.44e-05	0.00177	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.36e-05	0.00171	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ENO2—peripheral nervous system neoplasm	2.36e-05	0.00171	CbGpPWpGaD
Pitavastatin—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.35e-05	0.00171	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.35e-05	0.0017	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.33e-05	0.00169	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.31e-05	0.00168	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.31e-05	0.00167	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—TH—peripheral nervous system neoplasm	2.3e-05	0.00166	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.26e-05	0.00164	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.23e-05	0.00162	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.14e-05	0.00155	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.12e-05	0.00154	CbGpPWpGaD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	2.12e-05	0.00153	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.09e-05	0.00152	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.06e-05	0.00149	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.05e-05	0.00149	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	2.01e-05	0.00146	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—BCHE—peripheral nervous system neoplasm	1.99e-05	0.00144	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.98e-05	0.00144	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.94e-05	0.0014	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	1.92e-05	0.0014	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.92e-05	0.00139	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	1.92e-05	0.00139	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.9e-05	0.00138	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.87e-05	0.00136	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—TH—peripheral nervous system neoplasm	1.87e-05	0.00136	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.86e-05	0.00135	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	1.85e-05	0.00134	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.84e-05	0.00133	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	1.81e-05	0.00131	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	1.81e-05	0.00131	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.79e-05	0.0013	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.78e-05	0.00129	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.76e-05	0.00128	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.71e-05	0.00124	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.68e-05	0.00122	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.65e-05	0.0012	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	1.63e-05	0.00118	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	1.62e-05	0.00118	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.59e-05	0.00116	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.59e-05	0.00115	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.56e-05	0.00113	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.55e-05	0.00112	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.53e-05	0.00111	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	1.53e-05	0.00111	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GNAS—peripheral nervous system neoplasm	1.53e-05	0.00111	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	1.53e-05	0.00111	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ABCB1—peripheral nervous system neoplasm	1.5e-05	0.00109	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.46e-05	0.00106	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	1.44e-05	0.00104	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.39e-05	0.00101	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	1.38e-05	0.001	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.37e-05	0.000994	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.34e-05	0.000972	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.33e-05	0.000961	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.32e-05	0.000956	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.32e-05	0.000954	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.3e-05	0.000941	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	1.3e-05	0.000941	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.27e-05	0.000921	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.25e-05	0.000903	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.000886	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.22e-05	0.000882	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.2e-05	0.000867	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.17e-05	0.000851	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.17e-05	0.000845	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.15e-05	0.000836	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.15e-05	0.000835	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.15e-05	0.000831	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-05	0.000816	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000806	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.11e-05	0.000802	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.1e-05	0.000797	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.08e-05	0.000782	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.06e-05	0.000772	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.06e-05	0.000768	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.06e-05	0.000768	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.06e-05	0.000767	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.06e-05	0.000767	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.00076	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-05	0.000753	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.03e-05	0.000745	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1e-05	0.000728	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.8e-06	0.000711	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	9.66e-06	0.0007	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	9.63e-06	0.000698	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.62e-06	0.000697	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	9.51e-06	0.00069	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.44e-06	0.000684	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	9.38e-06	0.000681	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	9.27e-06	0.000672	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.07e-06	0.000658	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	9e-06	0.000652	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	8.94e-06	0.000649	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	8.66e-06	0.000628	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.43e-06	0.000611	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.26e-06	0.000599	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	7.88e-06	0.000572	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.74e-06	0.000561	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	7.72e-06	0.00056	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	7.3e-06	0.000529	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.16e-06	0.00052	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	6.99e-06	0.000507	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	6.95e-06	0.000504	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.78e-06	0.000492	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.09e-06	0.000441	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	5.9e-06	0.000428	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	5.87e-06	0.000426	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.82e-06	0.000422	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.73e-06	0.000415	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	5.69e-06	0.000412	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.63e-06	0.000408	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.6e-06	0.000406	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	5.55e-06	0.000402	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TH—peripheral nervous system neoplasm	5.52e-06	0.0004	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.14e-06	0.000373	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	5.06e-06	0.000367	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.91e-06	0.000356	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.83e-06	0.000351	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	4.8e-06	0.000348	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	4.64e-06	0.000337	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.58e-06	0.000332	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	4.53e-06	0.000329	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	4.52e-06	0.000328	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	4.5e-06	0.000327	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.45e-06	0.000322	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	4.42e-06	0.000321	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—peripheral nervous system neoplasm	4.12e-06	0.000299	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.95e-06	0.000286	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	3.69e-06	0.000267	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.62e-06	0.000262	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	3.55e-06	0.000258	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	3.4e-06	0.000246	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	3.36e-06	0.000244	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	3.17e-06	0.00023	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3e-06	0.000217	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	2.86e-06	0.000207	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.13e-06	0.000154	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.97e-06	0.000143	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.22e-06	8.87e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.22e-06	8.82e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.07e-06	7.73e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	9.95e-07	7.22e-05	CbGpPWpGaD
